Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV

Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Nathan, Hirnschall, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805474/
https://www.ncbi.nlm.nih.gov/pubmed/24167450
http://dx.doi.org/10.1371/journal.pmed.1001535
_version_ 1782477866044227584
author Ford, Nathan
Hirnschall, Gottfried
author_facet Ford, Nathan
Hirnschall, Gottfried
author_sort Ford, Nathan
collection PubMed
description Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order to achieve the levels of enrollment and retention in care required to maximize the prevention benefit of ART. Please see later in the article for the Editors' Summary
format Online
Article
Text
id pubmed-3805474
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38054742013-10-28 Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV Ford, Nathan Hirnschall, Gottfried PLoS Med Perspective Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order to achieve the levels of enrollment and retention in care required to maximize the prevention benefit of ART. Please see later in the article for the Editors' Summary Public Library of Science 2013-10-22 /pmc/articles/PMC3805474/ /pubmed/24167450 http://dx.doi.org/10.1371/journal.pmed.1001535 Text en
spellingShingle Perspective
Ford, Nathan
Hirnschall, Gottfried
Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title_full Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title_fullStr Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title_full_unstemmed Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title_short Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
title_sort modelling the strategic use of antiretroviral therapy for the treatment and prevention of hiv
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805474/
https://www.ncbi.nlm.nih.gov/pubmed/24167450
http://dx.doi.org/10.1371/journal.pmed.1001535
work_keys_str_mv AT fordnathan modellingthestrategicuseofantiretroviraltherapyforthetreatmentandpreventionofhiv
AT hirnschallgottfried modellingthestrategicuseofantiretroviraltherapyforthetreatmentandpreventionofhiv

Ejemplares similares